Mga Batayang Estadistika
| CIK | 1096738 |
SEC Filings
All companies that sell securities in the United States must register with the Securities and Exchange Commission (SEC) and file reports on a regular basis.
These reports include company annual reports (10K, 10Q), news updates (8K), investor presentations (found in 8Ks), insider trades (form 4), ownership reports (13D, and 13G), and reports related to the specific securities sold, such as registration statements and prospectus. This page shows recent SEC filings related to Epocrates Inc
SEC Filings (Chronological Order)
Halaman ini menyediakan daftar lengkap dan kronologis dari Pengajuan SEC, tidak termasuk pengajuan kepemilikan yang kami sediakan di tempat lain.
| March 25, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 15 CERTIFICATION AND NOTICE OF TERMINATION OF REGISTRATION UNDER SECTION 12(g) OF THE SECURITIES EXCHANGE ACT OF 1934 OR SUSPENSION OF DUTY TO FILE REPORTS UNDER SECTIONS 13 AND 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934. Commission File Number 001-35062 EPOCRATES, INC. (Exact name of registrant as specified in its char |
|
| March 13, 2013 |
EPOC / Epocrates Inc / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 2) Epocrates, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29429D103 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized to Receive No |
|
| March 12, 2013 |
BY‑LAWS EPOCRATES, INC. (the “Corporation”) EXHIBIT 3.1 BY‑LAWS of EPOCRATES, INC. (the “Corporation”) 1.Stockholders (a)Annual Meeting. The annual meeting of stockholders shall be held for the election of directors each year at such place, date and time as shall be designated by the Board of Directors. Any other proper business may be transacted at the annual meeting. If no date for the annual meeting is established or said meeting is not |
|
| March 12, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-181207 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-172906 UNDER THE SECURITIES ACT OF 1933 Epocrates, Inc. (Exact name of registrant as specified in its charter) Delaware 94-3326769 (State or other jurisdiction of incorporat |
|
| March 12, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-181207 POST-EFFECTIVE AMENDMENT NO. 1 TO FORM S-8 REGISTRATION STATEMENT NO. 333-172906 UNDER THE SECURITIES ACT OF 1933 Epocrates, Inc. (Exact name of registrant as specified in its charter) Delaware 94-3326769 (State or other jurisdiction of incorporat |
|
| March 12, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) March 11, 2013 Epocrates, Inc. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction of incorporation) (Commission File Numb |
|
| March 11, 2013 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) ý ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001- |
|
| March 6, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a-101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confide |
|
| February 21, 2013 |
EPOC / Epocrates Inc / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 (Amendment No. 1) Epocrates, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29429D103 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized to Receive No |
|
| February 14, 2013 |
EPOC / Epocrates Inc / INTERWEST PARTNERS VII L P - SC 13G/A Passive Investment SC 13G/A OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2010 Estimated average burden hours per response 10. |
|
| February 14, 2013 |
EPOC / Epocrates Inc / THREE ARCH PARTNERS II LP - SC 13G/A Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b) (Amendment No. 1)* Epocrates, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29429D103 (CUSIP Number) December 31, 2012 (Date of Event Which Requires Filing of this Statem |
|
| February 14, 2013 |
EX-A Exhibit A Joint Filing Statement We, the undersigned, hereby express our agreement that the attached Schedule 13G is filed on behalf of each of us. |
|
| February 13, 2013 |
EX-99.1 2 d483531dex991.htm EX-99.1 CUSIP NUMBER 29429D103 13G Page 16 of 17 Pages Exhibit 99.1 Pursuant to Rule 13d-1(k)(1)(iii) of Regulation 13D-G of the General Rules and Regulations of the Securities and Exchange Commission under the Securities and Exchange Act of 1934, as amended, the undersigned agrees that the statement to which this Exhibit is attached is filed on behalf of each of them. |
|
| February 13, 2013 |
EPOC / Epocrates Inc / DRAPER FISHER JURVETSON FUND V LP - SC 13G/A Passive Investment SC 13G/A Securities and Exchange Commission Washington, DC 20549 Schedule 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240. |
|
| February 11, 2013 |
Use these links to rapidly review the document TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 29, 2013 |
EPOC / Epocrates Inc / GAMCO INVESTORS, INC. ET AL Activist Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Epocrates, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29429D103 (CUSIP Number) David Goldman GAMCO Investors, Inc. One Corporate Center Rye, New York 10580-1435 (914) 921-5000 (Name, Address and Telephone Number of Person Authorized to Receive Notices and Communic |
|
| January 25, 2013 |
Use these links to rapidly review the document TABLE OF CONTENTS TABLE OF CONTENTS Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D. |
|
| January 17, 2013 |
EPOC / Epocrates Inc / ATHENAHEALTH INC - SC 13D Activist Investment UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13D Under the Securities Exchange Act of 1934 Epocrates, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 29429D103 (CUSIP Number) Daniel H. Orenstein, Esq. athenahealth, Inc. 311 Arsenal Street Watertown, Massachusetts 02472 (617) 402-1000 Lawrence S. Wittenberg, Esq. John |
|
| January 16, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 11, 2013 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction (Commission File Number) (IRS Employ |
|
| January 10, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 6, 2013 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction (Commission File Number) (IRS Employe |
|
| January 10, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a -101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confid |
|
| January 8, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 7, 2013 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File |
|
| January 8, 2013 |
CORPORATE PARTICIPANTS Andrew J. Hurd President, Chief Executive Officer and Interim Chief Financial Officer, Epocrates, Inc. Timothy M. Adams Chief Financial Officer, Treasurer & Senior VP, athenahealth, Inc. Jonathan S. Bush Chairman, President & Chief Executive Officer, athenahealth, Inc. OTHER PARTICIPANTS Lisa C. Gill Analyst, JPMorgan Securities LLC MANAGEMENT DISCUSSION SECTION Lisa C. Gill |
|
| January 7, 2013 |
Title: athenahealth® to acquire epocrates® Title: athenahealth® to acquire epocrates® Jeremy Delinsky - Chief Technology Officer: This is the big opportunity that we have been looking for. |
|
| January 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a -101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confid |
|
| January 7, 2013 |
Exhibit 99.1 athenahealth to Acquire Mobile Health Leader Epocrates Acquisition will accelerate athenahealth's vision to build the nation's health information backbone; companies will combine forces to redefine physician mobile experience and point-of-care toolset WATERTOWN, MA, January 7, 2013 - athenahealth, Inc.(NASDAQ: ATHN), a leading provider of cloud-based electronic health record (EHR), pr |
|
| January 7, 2013 |
Entry into a Material Definitive Agreement, Financial Statements and Exhibits - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2013 Epocrates, Inc. |
|
| January 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a -101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confid |
|
| January 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a -101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confid |
|
| January 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 7, 2013 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File |
|
| January 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 OR 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported) January 7, 2013 athenahealth, Inc. (Exact name of registrant as specified in its charter) Delaware 001-33689 04-3387530 (State or other jurisdiction of incorporation) (Commission File |
|
| January 7, 2013 |
EX-99.1 4 a13-22441ex99d1.htm EX-99.1 Exhibit 99.1 athenahealth to Acquire Mobile Health Leader Epocrates Acquisition will accelerate athenahealth’s vision to build the nation’s health information backbone; companies will combine forces to redefine physician mobile experience and point-of-care toolset WATERTOWN, MA, January 7, 2013 - athenahealth, Inc.(NASDAQ: ATHN), a leading provider of cloud-ba |
|
| January 7, 2013 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER among ATHENAHEALTH, INC., Echo Merger Sub, Inc. and Epocrates, Inc. Dated as of January 7, 2013 This Agreement and Plan of Merger (the “Agreement”) contains representations and warranties that athenahealth, Inc., Epocrates, Inc. and Echo Merger Sub, Inc. made to one another. These representations and warranties were made only for the purposes of the Agreeme |
|
| January 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a -101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confid |
|
| January 7, 2013 |
Exhibit 2.2 VOTING AGREEMENT This Voting Agreement (“Agreement”), dated as of January 7, 2013, is made by and between athenahealth, Inc., a Delaware corporation (“Parent”), and the undersigned holder (the “Stockholder”) of shares of common stock, par value $0.001 per share, or other securities of Epocrates, Inc., a Delaware corporation (the “Company”). WHEREAS, Parent, the Company, and Echo Merger |
|
| January 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a -101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confid |
|
| January 7, 2013 |
athenahealthepocratesjpm An d y H u rd , P re s ident , CEO & Inte r im CFO J an u ary 2013 JP Morgan Healthcare Conference 2 Safe Harbor Statement 3 This presentation contains forward-looking statements, which are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995, including statements reflecting athenahealth, Inc. |
|
| January 7, 2013 |
Exhibit 2.1 AGREEMENT AND PLAN OF MERGER among ATHENAHEALTH, INC., ECHO MERGER SUB, INC. and EPOCRATES, INC. Dated as of January 7, 2013 TABLE OF CONTENTS Page ARTICLE I THE MERGER SECTION 1.01 The Merger 1 SECTION 1.02 Effective Time; Closing 2 SECTION 1.03 Effect of the Merger 2 SECTION 1.04 Certificate of Incorporation; By-laws 2 SECTION 1.05 Directors and Officers 2 ARTICLE II CONVERSION OF SE |
|
| January 7, 2013 |
Exhibit 10.1 VOTING AGREEMENT This Voting Agreement (“Agreement”), dated as of January 7, 2013, is made by and between athenahealth, Inc., a Delaware corporation (“Parent”), and the undersigned holder (the “Stockholder”) of shares of common stock, par value $0.001 per share, or other securities of Epocrates, Inc., a Delaware corporation (the “Company”). WHEREAS, Parent, the Company, and Echo Merge |
|
| January 7, 2013 |
C O R P O R A T E P A R T I C I P A N T S C O R P O R A T E P A R T I C I P A N T S Dana Quattrochi athenahealth, Inc. - IR Jonathan Bush athenahealth, Inc - Chairman and CEO Tim Adams athenahealth, Inc - CFO Andy Hurd Epocrates - President and CEO Rob Cosinuke athenahealth, Inc. - Chief Marketing Officer C O N F E R E N C E C A L L P A R T I C I P A N T S Sean Wieland Piper Jaffray & Co. - Analyst Jamie Stockton Wells Fargo Securities, L |
|
| January 7, 2013 |
epocratestownhall1713fin Regulation M-A Disclosure In connection with the acquisition of Epocrates, Inc. |
|
| January 7, 2013 |
DEFA14A 1 a13-224410defa14a.htm DEFA14A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a -101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box |
|
| January 7, 2013 |
EX-2.1 2 a13-22441ex2d1.htm EX-2.1 Exhibit 2.1 AGREEMENT AND PLAN OF MERGER among ATHENAHEALTH, INC., ECHO MERGER SUB, INC. and EPOCRATES, INC. Dated as of January 7, 2013 TABLE OF CONTENTS Page ARTICLE I THE MERGER SECTION 1.01 The Merger 1 SECTION 1.02 Effective Time; Closing 2 SECTION 1.03 Effect of the Merger 2 SECTION 1.04 Certificate of Incorporation; By-laws 2 SECTION 1.05 Directors and Off |
|
| January 7, 2013 |
Exhibit 99.1 athenahealth to Acquire Mobile Health Leader Epocrates Acquisition will accelerate athenahealth’s vision to build the nation’s health information backbone; companies will combine forces to redefine physician mobile experience and point-of-care toolset WATERTOWN, MA, January 7, 2013 - athenahealth, Inc.(NASDAQ: ATHN), a leading provider of cloud-based electronic health record (EHR), pr |
|
| January 7, 2013 |
AthenaHealth Acquires Epocrates, the Angry Birds of Healt AthenaHealth Acquires Epocrates, the Angry Birds of Healt By Peter Burrows & Alex Nussbaum - Jan 7, 2013 9:59 AM ET Athenahealth Inc. |
|
| January 7, 2013 |
Exhibit 2.2 VOTING AGREEMENT This Voting Agreement (“Agreement”), dated as of January 7, 2013, is made by and between athenahealth, Inc., a Delaware corporation (“Parent”), and the undersigned holder (the “Stockholder”) of shares of common stock, par value $0.001 per share, or other securities of Epocrates, Inc., a Delaware corporation (the “Company”). WHEREAS, Parent, the Company, and Echo Merger |
|
| January 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 7, 2013 Epocrates, Inc. |
|
| January 7, 2013 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 14A (Rule 14a -101) INFORMATION REQUIRED IN PROXY STATEMENT SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. ) Filed by the Registrant x Filed by a Party other than the Registrant o Check the appropriate box: o Preliminary Proxy Statement o Confid |
|
| December 28, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): December 26, 2012 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction (Commission File Number) (IRS Emplo |
|
| November 9, 2012 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-3506 |
|
| October 30, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 30, 2012 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction (Commission File Number) (IRS Employ |
|
| October 30, 2012 |
Epocrates Announces Third Quarter 2012 Results CONTACT INFORMATION: INVESTORS & MEDIA: Erica Sniad Morgenstern Senior Director, Public Relations and Communications Epocrates, Inc. |
|
| October 24, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 23, 2012 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction (Commission File Number) (IRS Employ |
|
| October 2, 2012 |
Submission of Matters to a Vote of Security Holders UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): October 2, 2012 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction (Commission File Number) (IRS Employe |
|
| August 30, 2012 |
SCHEDULE 14A INFORMATION Proxy Statement Pursuant to Section 14(a) of the Securities Exchange Act of 1934 (Amendment No. |
|
| August 14, 2012 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q ý QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35062 Epo |
|
| August 7, 2012 |
Costs Associated with Exit or Disposal Activities - 8-K/A UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K/A Amendment No. 1 CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2012 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction (Commission File |
|
| August 7, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): August 2, 2012 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction (Commission File Number) (IRS Employer |
|
| August 7, 2012 |
Epocrates Announces Second Quarter 2012 Results Reaffirms 2012 Revenue and Earnings Guidance CONTACT INFORMATION: INVESTORS & MEDIA: Erica Sniad Morgenstern Senior Director, Public Relations and Communications Epocrates, Inc. |
|
| August 7, 2012 |
August 6, 2012 Ms. Heather Gervais Epocrates, Inc. 200 Princeton South Corporate Center, Suite 340 Ewing, New Jersey 08628 Re: Terms of Employment Dear Heather: On behalf of Epocrates, Inc. (“Epocrates” or the “Company”), I am pleased to set forth the terms of your continued employment as SVP, Commercial Operations. The terms and conditions of your position and employment relationship with the Com |
|
| July 19, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): July 18, 2012 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction (Commission File Number) (IRS Employer |
|
| May 16, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 14, 2012 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction (Commission File Number) (IRS Employer I |
|
| May 11, 2012 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-Q x QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended March 31, 2012 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission file number: 001-35062 Ep |
|
| May 7, 2012 |
As filed with the Securities and Exchange Commission on May 7, 2012 Registration No. |
|
| May 1, 2012 |
Exhibit 99.1 CONTACT INFORMATION: INVESTORS & MEDIA: Erica Sniad Morgenstern Senior Director, Public Relations and Communications Epocrates, Inc. (650) 227-6907 [email protected] Epocrates Announces First Quarter 2012 Results - Reaffirms 2012 Revenue Guidance and Announces Earnings Guidance SAN MATEO, Calif. — May 1, 2012 — Epocrates, Inc. (NASDAQ: EPOC), a leading physician platform for clinical c |
|
| May 1, 2012 |
Financial Statements and Exhibits, Results of Operations and Financial Condition - 8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): May 1, 2012 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction (Commission File Number) (IRS Employer Id |
|
| April 30, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2012 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction (Commission File Number) (IRS Employer |
|
| April 27, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): April 24, 2012 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction of incorporation) (Commission File Num |
|
| March 26, 2012 |
Exhibit 10.1 March 22, 2012 Andrew Hurd Re: Offer of Employment Dear Andrew On behalf of Epocrates, Inc. (“Epocrates” or the “Company”), I am pleased to offer you the full-time position of President and Chief Executive Officer. The terms and conditions of your new position and employment relationship with the Company are as set forth below: 1. Position and Work Schedule. a. You will become the Pre |
|
| March 26, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): March 21, 2012 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction (Commission File Number) (IRS Employer |
|
| March 19, 2012 |
Exhibit 10.20 December 9, 2011 Peter Brandt Re: Offer of Employment Dear Peter On behalf of Epocrates, Inc. (“Epocrates” or the “Company”), I am pleased to offer you the full-time position of Interim President and Chief Executive Officer. The terms and conditions of your new position and employment relationship with the Company are as set forth below: 1. Position and Work Schedule. a. You will con |
|
| March 19, 2012 |
Exhibit 10.17 November 17, 2011 Ms. Rosemary A. Crane Re: Separation Agreement Dear Rose: This letter sets forth the terms of the separation agreement (the “Agreement”) between you and Epocrates, Inc. (“Epocrates” or the “Company”). 1. Separation Date; Board Resignation. Your last day of employment and your employment termination date was November 16, 2011 (the “Separation Date”). Such termination |
|
| March 19, 2012 |
2010 and 2011 Executive Officer Compensation Arrangements Exhibit 10.28 2010 and 2011 Executive Officer Compensation Arrangements Executive Officer 2010 Base Salary Rate 2010 Target Bonus as % of Annual Base Salary Rate 2011 Base Salary Rate 2011 Target Bonus as % of Annual Base Salary Rate Peter C. Brandt (1) $ — — $ 305,000 — Interim President and Chief Executive Officer Patrick D. Spangler (2) $ 300,000 60 $ 300,000 60 Chief Financial Officer Matthew |
|
| March 19, 2012 |
Table of Contents UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 10-K (Mark One) x ANNUAL REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the Fiscal Year Ended December 31, 2011 OR o TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to . Commission file number: 001- |
|
| March 19, 2012 |
EPOCRATES, INC. November 7, 2011 Exhibit 10.21 EPOCRATES, INC. November 7, 2011 Joe Kleine 12 Norwood Lane Westport, CT 06880 Re: Separation & Release Agreement Dear Joe: This letter agreement (this “Agreement”) will confirm our understanding with regard to your termination of employment with Epocrates, Inc. (the “Company”). 1. Separation. Your last day of work with the Company and your employment termination date is November 30, |
|
| February 28, 2012 |
t UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 24, 2012 EPOCRATES, INC. (Exact name of Registrant as specified in its charter) Delaware (State or other jurisdiction of incorporation) 001-35062 (Commission File Number) 9 |
|
| February 28, 2012 |
Exhibit 99.1 CONTACT INFORMATION: INVESTORS & MEDIA: Erica Sniad Morgenstern Senior Director, Public Relations and Communications Epocrates, Inc. (650) 227-6907 [email protected] Epocrates Streamlines Strategic Focus and Reports Fourth Quarter and Full Year 2011 Results - Company to Focus on Providing Trusted Content and Collaborative Solutions for Physicians - Company to Explore Strategic Alternat |
|
| February 22, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): February 15, 2012 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction (Commission File Number) (IRS Emplo |
|
| February 14, 2012 |
EPOC / Epocrates Inc / THREE ARCH PARTNERS II LP - SCHEDULE 13G Passive Investment SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Schedule 13G INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO RULES 13d-1 (b), (c) AND (d) AND AMENDMENTS THERETO FILED PURSUANT TO 13d-2 (b) (Amendment No. )* Epocrates, Inc. (Name of Issuer) Common Stock (Title of Class of Securities) 29429D103 (CUSIP Number) December 31, 2011 (Date of Event Which Requires Filing of this Stateme |
|
| February 14, 2012 |
EPOC / Epocrates Inc / INTERWEST PARTNERS VII L P - SCHEDULE 13G Passive Investment Schedule 13G OMB APPROVAL OMB Number: 3235-0145 Expires: February 28, 2010 Estimated average burden hours per response 10. |
|
| February 9, 2012 |
EX-99.1 2 misc1.htm MISCELLANEOUS EXHIBITS In accordance with Securities and Exchange Commission Release No. 34-39538 (January 12, 1998), this Statement is being filed by Credit Suisse AG (the "Bank"), a Swiss bank, on behalf of its subsidiaries to the extent that they constitute the Investment Banking division (the "Investment Banking division"), the Alternative Investments business (the "AI Busi |
|
| February 9, 2012 |
EPOC / Epocrates Inc / CREDIT SUISSE AG/ - NONE Passive Investment Schedule 13G UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. n/a )* Epocrates, Inc. (Name of Issuer) Common Stock, par value $0.001 per share (Title of Class of Securities) 29429D103 (CUSIP Number) Calendar Year 2011 (Date of Event Which Requires Filing of this Statement) Check the appropriate box to desi |
|
| February 6, 2012 |
Statement pursuant to Rule 13d-1(k)(1)(iii) Exhibit 99.1 Pursuant to Rule 13d-1(k)(1)(iii) of Regulation 13D-G of the General Rules and Regulations of the Securities and Exchange Commission under the Securities and Exchange Act of 1934, as amended, the undersigned agrees that the statement to which this Exhibit is attached is filed on behalf of each of them. Dated: February 6, 2012 Draper Fisher J |
|
| February 6, 2012 |
EPOC / Epocrates Inc / DRAPER FISHER JURVETSON FUND V LP - SCHEDULE 13G Passive Investment Schedule 13G Securities and Exchange Commission Washington, DC 20549 Schedule 13G (Rule 13d-102) INFORMATION TO BE INCLUDED IN STATEMENTS FILED PURSUANT TO §240. |
|
| January 20, 2012 |
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d) of The Securities Exchange Act of 1934 Date of Report (Date of earliest event reported): January 5, 2012 EPOCRATES, INC. (Exact name of registrant as specified in its charter) Delaware 001-35062 94-3326769 (State or other jurisdiction (Commission File Number) (IRS Employe |
